Update on the imaging techniques in the diagnosis of diabetic retinopathy

Curr Diabetes Rev. 2012 May;8(3):200-8. doi: 10.2174/157339912800564025.

Abstract

Diabetic retinopathy is one of the leading causes of vision loss worldwide. Fluorescein angiogram still plays a primary role in its diagnosis but new non-invasive technologies as optical coherence tomography, fundus autofluorescence and microperimetry are gaining popularity in the last years. Anatomical changes found with these devices have been widely described but their correlation with visual function needs to be assessed and several features have been proposed as indicators of visual prognosis. The aim of this paper is to give a scope of the actual role of these techniques in the evaluation of retinal impairment secondary to diabetes.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / diagnosis*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Retinopathy / diagnosis*
  • Diabetic Retinopathy / etiology
  • Diabetic Retinopathy / physiopathology
  • Female
  • Fluorescein Angiography* / methods
  • Fluorescein Angiography* / trends
  • Fundus Oculi
  • Humans
  • Male
  • Tomography, Optical Coherence* / methods
  • Tomography, Optical Coherence* / trends
  • Visual Acuity
  • Visual Field Tests* / methods
  • Visual Field Tests* / trends
  • Visual Fields